drugset / Trial / NCT04484532
Evaluation of Antibody Response to High-Dose Seasonal Influenza Vaccination in Patients With Myeloid Malignancy Receiving Chemotherapy and Healthy Volunteers
NaSingle-groupOpen-labelSupportive care
Summary
This pilot research trial studies the antibody response to high-dose seasonal influenza vaccination in patients with myeloid malignancy receiving chemotherapy and healthy volunteers. Evaluating antibody response to high-dose seasonal influenza vaccine may serve as a basis for vaccine recommendations in patients with myeloid malignancies and provide insights into the status of the immune system in these patients.
Timeline
- Start
- 2017-10-17
- Primary completion
- 2022-06-07
- Completion
- 2022-06-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Agriflu | Vaccine | — | Intramuscular |
| Subject | Flublok | Vaccine | — | Intramuscular |
| Subject | Fluvirin | Vaccine | — | Intramuscular |
| Subject | Influenza Virus Vaccine | Vaccine | — | Intramuscular |